{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:37:34Z","timestamp":1787063854347,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Center for Human Reproduction"},{"name":"The Foundation for Reproductive Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Because often introduced without proper validation studies, so-called \u201cadd-ons\u201d to IVF have adversely affected in vitro fertilization (IVF) outcomes worldwide. All-freeze cycles (embryo banking, EB) with subsequently deferred thaw cycles are such an \u201cadd-on\u201d and, because of greatly diverging reported outcomes, have become increasingly controversial. Based on \u201cmodeling\u201d with selected patient populations, we in this study investigated whether reported outcome discrepancies may be the consequence of biased patient selection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In four distinct retrospective case control studies, we modeled in four cohort pairings how cryopreservation with subsequent thaw cycles affects outcomes differently in good-, average- and poor-prognosis patients: (i) 127 fresh vs. 193 frozen donor-recipient cycles to model best-prognosis patients; (ii) 741 autologous fresh non-donor IVF cycles vs. 217 autologous frozen non-donor IVF cycles to model average prognosis patients; (iii) 143 favorably selected autologous non-donor IVF cycles vs. the same 217 frozen autologous cycles non-donor to monitor good- vs. average-prognosis patients; and (iv) 598 average and poor-prognosis autologous non-donor cycles vs. the same 217 frozen autologous non-donor cycles to model poor vs. average prognosis patients. In best-prognosis patients, EB marginally improved IVF outcomes. In unselected patients, EB had no effects. In poor-prognosis patients, EB adversely affected IVF outcomes. Unexpectedly, the study also discovered independent-of-age-associated chromosomal abnormalities, a previously unreported effect of recipient age on miscarriage risk in donor-egg recipients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In poor-prognosis patients, EB cycles should be considered contraindicated. In intermediate-prognosis patients EB does not appear to change outcomes, not warranting additional cost and time delays. Therefore, only good-prognosis patients are candidates for EB, though they will experience only marginal benefits that may not be cost-effective.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01269-0","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T02:01:32Z","timestamp":1694397692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The utility of all-freeze IVF cycles depends on the composition of study populations"],"prefix":"10.1186","volume":"16","author":[{"given":"Norbert","family":"Gleicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Patrizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David. H.","family":"Barad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"issue":"2","key":"1269_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.fertnstert.2012.09.044","volume":"99","author":"BS Shapiro","year":"2013","unstructured":"Shapiro BS, Daneshmand ST, Restrepo H, Garner FC, Aguirre M, Hudson C. Matched-cohort comparison of single-embryo transfers in fresh and frozen-thawed embryo transfer cycles. Fertil Steril. 2013;99(2):389\u201392.","journal-title":"Fertil Steril"},{"issue":"1","key":"1269_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.fertnstert.2014.04.018","volume":"102","author":"BS Shapiro","year":"2014","unstructured":"Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C. Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer. Fertil Steril. 2014;102(1):3\u20139.","journal-title":"Fertil Steril"},{"issue":"5","key":"1269_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.fertnstert.2015.01.045","volume":"103","author":"M Roque","year":"2015","unstructured":"Roque M, Valle M, Guimar\u00e3es F, Sampalo M, Geber S. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril. 2015;103(5):1190\u20133.","journal-title":"Fertil Steril"},{"issue":"7","key":"1269_CR4","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.fertnstert.2016.08.047","volume":"106","author":"A Maheshwari","year":"2016","unstructured":"Maheshwari A, Amalray Raja E, Bhattacharya S. Obstetrics and perinatal outcomes after either fresh or thawed frozen embryo transfer: an analysis of 112,432 singleton pregnancies recorded in the Human Fertilisation and Embryology Authority anonymized dataset. Fertil Steril. 2016;106(7):1703\u20138.","journal-title":"Fertil Steril"},{"issue":"5","key":"1269_CR5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.fertnstert.2018.05.024","volume":"110","author":"AS Acharya","year":"2018","unstructured":"Acharya AS, Acharya CR, Bishop K, Harris B, Raburn D, Muasher SJ. Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate ad low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology Registry. Fertil Steril. 2018;110(5):880\u20137.","journal-title":"Fertil Steril"},{"key":"1269_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fendo.2020.00019","volume":"11","author":"R Orvieto","year":"2020","unstructured":"Orvieto R, Kirshenbaum M, Gleicher N. Is embryo cryopreservation causing macrosomia-and what else? Front Endocrinol (Lausanne). 2020;11:19.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1269_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/humrep\/dex004","volume":"32","author":"J Harper","year":"2017","unstructured":"Harper J, Jackson E, Sermon K, Aitken RJ, Harbottle S, Mocanu E, Hardarson T, Mathur R, Viville S, Vail A, Lundin K. Adjuncts in the IVF laboratory: where is the evidence for \u201cadd-on\u201d interventions? Hum Reprod. 2017;32(3):485\u201391.","journal-title":"Hum Reprod"},{"key":"1269_CR8","doi-asserted-by":"crossref","unstructured":"Gleicher N, Kushnir VA, Barad DH. Worldwide declines of in vitro fertilization (IVF) birth rates and their probable causes. Hum Reprod Open 2019;(3):hoz017","DOI":"10.1093\/hropen\/hoz017"},{"issue":"10","key":"1269_CR9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1093\/humrep\/deaa204","volume":"35","author":"RZ Ben","year":"2020","unstructured":"Ben RZ. Should we still offer elective freezing of all embryos in all IVF cycles? Hum Reprod. 2020;35(10):2179\u201381.","journal-title":"Hum Reprod"},{"key":"1269_CR10","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0140-6736(18)32843-5","volume":"393","author":"D Wei","year":"2019","unstructured":"Wei D, Liu JY, Sun Y, Shi Y, Zhang B, Liu JQ, Tan J, Liang X, Cao Y, Wang Z, Qin Y, Zhao H, Zhou Y, Ren H, Hao G, Ling X, Zhao J, Zhang Y, Qi X, Zhang L, Deng X, Chen X, Zhu Y, Wang X, Tian LF, Lv Q, Ma X, Zhang H, Legro RS, Chen ZJ. Frozen versus fresh single blastocyst transfer in ovulating women: a multicenter, randomized controlled trial. Lancet. 2019;393:1310\u20138.","journal-title":"Lancet"},{"issue":"2","key":"1269_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1056\/NEJMoa1705334","volume":"378","author":"Y Shi","year":"2018","unstructured":"Shi Y, Sun Y, Hao C, Zhang H, Wei D, Zhang Y, Zhu Y, Deng X, Qi X, Li H, Ma X, Ren H, Wang Y, Zhang D, Wang B, Liu F, Wu Q, Wang Z, Bai H, Li Y, Zhou Y, Sun M, Liu H, Li J, Zhang L, Chen X, Zhang S, Sun X, Legro RS, Chen ZJ. Transfer of fresh versus frozen embryos in ovulatory women. N Engl J Med. 2018;378(2):126\u201336.","journal-title":"N Engl J Med"},{"key":"1269_CR12","doi-asserted-by":"publisher","first-page":"m2519","DOI":"10.1136\/bmj.m2519","volume":"370","author":"S Stormlund","year":"2020","unstructured":"Stormlund S, Sopa N, Zedeler A, Bogstad J, Pr\u00e6torius L, Svarre Nielsen H, Laczna Kitlinski M, Skouby SO, Mikkelsen AL, L\u00e6rke Spangmose A, Vikkels\u00f8 Jeppesen J, Khatibi A, la Cour FN, Ziebe S, Polyzos NP, Bergh C, Humaidan P. Freeze-all versus fresh blastocyst transfer strategy during in vitro fertilisation i women with regular menstrual cycles: muticentre randomised controlled trial. BMJ. 2020;370:m2519.","journal-title":"BMJ"},{"key":"1269_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12967-016-0924-7","volume":"14","author":"N Gleicher","year":"2016","unstructured":"Gleicher N, Kushnir VA, Sen A, Darmon SK, Weghofer A, Wu Y-G, Wanh Q, Zhang L, Alertini DF, Barad DH. Definition by SH, AMH, and embryo numbers of good, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH. J Transl Med. 2016;14:171.","journal-title":"J Transl Med"},{"issue":"1","key":"1269_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12958-016-0181-x","volume":"14","author":"Y-G Wu","year":"2016","unstructured":"Wu Y-G, Lazzroni-Tealdi E, Wang Q, Zhang L, Barad DH, Kushnir VA, Darmon SK, Albertini DF, Gleicher N. Different effectiveness of closed embryo culture system with time-lapse imaging (EmbryoScope(TM)) in comparison to standard manual embryology in good and poor prognosis patients: a prospectively randomized pilot study. Reprod Endocrinol Biol. 2016;14(1):49.","journal-title":"Reprod Endocrinol Biol"},{"key":"1269_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1477-7827-10-48","volume":"10","author":"N Gleicher","year":"2017","unstructured":"Gleicher N, Kim A, Weghofer A, Barad D. Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women. Reprod Biol Endocrinol. 2017;10:48.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"1269_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0015-0282(16)54722-0","volume":"56","author":"D Levran","year":"1991","unstructured":"Levran D, Ben-Shlomo I, Dor Z, Ben-Rafael Z, Nebel L, Mashiach S. Aging of endometrium and oocytes: observations on conception and abortion rates in an egg donation model. Fertil Steril. 1991;56(6):1091\u20134.","journal-title":"Fertil Steril"},{"issue":"5","key":"1269_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S0015-0282(02)03371-X","volume":"78","author":"JP Toner","year":"2002","unstructured":"Toner JP, Grainger DA, Frazier LM. Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, 1996\u20131998. Fertil Steril. 2002;78(5):1038\u201345.","journal-title":"Fertil Steril"},{"issue":"10","key":"1269_CR18","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1007\/s10815-020-01934-z","volume":"37","author":"K Lattes","year":"2020","unstructured":"Lattes K, L\u00f3pez S, Checa MA, Brassesco M, Garcia D, Vassena R. A freeze-all strategy does not increase live birth rates in women of advanced reproductive age. J Assist Reprod Genet. 2020;37(10):2442\u201351.","journal-title":"J Assist Reprod Genet"},{"key":"1269_CR19","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/biomedicines10071505","volume":"10","author":"N Gleicher","year":"2022","unstructured":"Gleicher N, Darmon S, Patrizio P, Barad DH. Reconsidering the Polycystic Ovary Syndrome (PCOS). Biomedicines. 2022;10:1505.","journal-title":"Biomedicines"},{"issue":"6","key":"1269_CR20","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/01.AOG.0000264065.37661.a0","volume":"109","author":"DH Barad","year":"2007","unstructured":"Barad DH, Weghofer A, Gleicher N. Age-specific levels of basal follicle stimulating hormone assessment of ovarian function. Obstet Gynecol. 2007;109(6):1404\u201310.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"1269_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.rbmo.2010.12.002","volume":"22","author":"DH Barad","year":"2010","unstructured":"Barad DH, Weghofer A, Gleicher N. Utility of age-specific serum anti-M\u00fcllerian hormone concentrations. Reprod Biomed Online. 2010;22(3):284\u201391.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"1269_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/JOE-15-0246","volume":"226","author":"YG Wu","year":"2015","unstructured":"Wu YG, Barad DH, Kushnir VA, Lazzaroni E, Wang Q, Albertini DF, Gleicher N. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol. 2015;226(3):167\u201380.","journal-title":"J Endocrinol"},{"issue":"1","key":"1269_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13048-018-0398-8","volume":"11","author":"Y-G Wu","year":"2018","unstructured":"Wu Y-G, Barad DH, Kushnir VA, Wang Q, Zhang L, Darmon SK, Albertini DF, Gleicher N. With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization. J Ovarian Res. 2018;11(1):23.","journal-title":"J Ovarian Res"},{"issue":"3","key":"1269_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0015-0282(97)00575-X","volume":"69","author":"ES Surrey","year":"1998","unstructured":"Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril. 1998;69(3):419\u201324.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01269-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T01:29:08Z","timestamp":1700443748000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01269-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01269-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients consented to the use of their medical records for research purposes, as long as those records were anonymized, prohibiting their identification. Since this study only involved anonymized electronic medical records and this condition, therefore, was met, this study was approved by the center\u2019s IRB in expedited format.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"N.G. and D.H.B. are listed as co-owners of several already awarded and still pending U.S. patents, some claiming benefits from androgen supplementation in women with low functional ovarian reserve, a topic addressed in this manuscript. Others relate to diagnostic and potential therapeutic benefits of AMH, also marginally addressed in this manuscript. N.G. is a shareholder in Fertility Nutraceuticals, LLC, which produces a DHEA product, and is the owner of The CHR., where much of the research reported in this manuscript was performed. N.G. and D.H.B. also receive patent royalties from Fertility Nutraceuticals, LLC. N.G. and D.H.B. in the past have received research support, travel funding, and lecture fees from various Pharma and medical device companies, none, however, over the last three years and none in any way related to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}